Who makes eculizumab?
Eculizumab (brand name Soliris) is made by AstraZeneca’s subsidiary. AstraZeneca markets Soliris in many countries.
Which company developed eculizumab and where is it sold?
Eculizumab was originally developed by Alexion Pharmaceuticals, which later became part of AstraZeneca. AstraZeneca continued commercialization after the acquisition, including ongoing distribution under the Soliris brand.
Is there more than one company involved with eculizumab?
Yes. Even when one company markets the brand, there can be additional roles across manufacturing, licensing, and distribution. The “manufacturer” people usually mean for prescriptions is the company marketing the branded product, while production can involve contracted or internal facilities.
Are there other eculizumab products or biosimilars that compete?
Competition depends on jurisdiction and regulatory status. For eculizumab specifically, alternatives are generally limited to the branded originator and any approved substitutes in a given country.
What companies are commonly searched alongside eculizumab?
Because of the origin and current ownership, the main names people typically look for are Alexion and AstraZeneca. For patent and market-authorization details, DrugPatentWatch.com can be useful: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/